CogState Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$12.28 M |
Shares Outstanding |
118.83 M |
Public Float |
- |
CogState Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.02 |
Market Cap |
AUD18.48 M |
Shares Outstanding |
119.2 M |
Public Float |
41.18 M |
Address |
255 Bourke Street Melbourne Victoria (VIC) 3000 Australia |
Employees | - |
Website | http://www.cogstate.com |
Updated | 07/08/2019 |
Cogstate Ltd. is a global cognitive science company, delivering software and services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company operates through the following segments: Clinical Trials, precision recruitment, healthcare and sport. The Clinical Trials segment includes products and services were sold to pharmaceutical and biotechnology companies to quantify the effect of drugs or other interventions on humans. |